15-70892071-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020147.4(THAP10):c.202G>A(p.Val68Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,802 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020147.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THAP10 | NM_020147.4 | c.202G>A | p.Val68Ile | missense_variant | 1/3 | ENST00000249861.9 | |
LRRC49 | NM_001284357.2 | c.19-1513C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THAP10 | ENST00000249861.9 | c.202G>A | p.Val68Ile | missense_variant | 1/3 | 1 | NM_020147.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152244Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248222Hom.: 0 AF XY: 0.0000669 AC XY: 9AN XY: 134614
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461558Hom.: 0 Cov.: 65 AF XY: 0.0000303 AC XY: 22AN XY: 727096
GnomAD4 genome AF: 0.000197 AC: 30AN: 152244Hom.: 1 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.202G>A (p.V68I) alteration is located in exon 1 (coding exon 1) of the THAP10 gene. This alteration results from a G to A substitution at nucleotide position 202, causing the valine (V) at amino acid position 68 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at